Revisiting estrogen for the treatment of endocrine-resistant breast cancer: Novel therapeutic approaches
Taketa T, Correa AM, Suzuki A, Blum MA, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S , Hofstetter WL, Ajani JA
The practical gap between 92% and 100% is small, and it shrinks further when you factor in the real-world variability of IV preparations (concentration accuracy, storage conditions, administration rate)
It acts more like a system-wide signal touching multiple pathways at once, which is part of why its effects are so broad and, honestly, a bit unusual for something this small
The follicular concentration of Hcy showed a negative correlation with the clinical pregnancies ( r = 0.298
[DOI] [PMC free article] [PubMed] 429.Michaowicz J, Wuka A, Bukowska B